Symposium on ATMPs: Next-gen Therapies for Next-gen Patients
‘Next-gen Therapies for Next-gen Patients’ brings together leading clinical experts in the field with academic, industry and regulatory stakeholders to discuss recent innovations and address key issues such as cross-border access, data collection, reimbursement, and the regulatory landscape in Belgium. The symposium features keynote addresses by Gloria Ghéquière (cabinet Vandenbroucke) on fostering access to ATMPs (Advanced Therapy Medicinal Products) in Belgium and Europe, and Prof. Dr. Arjan Lankester (Leiden University Medical Center) on the journey from pre-clinical development to cross-border gene therapy.
With talk @ 09:50 'CAR-Ts in pediatric hemato-oncology' by CRIG group leader Prof. Barbara De Moerloose (MD, PhD)
- When: May 23, 2025 - 08:15 - 15:00
- Where: Wintercircus, Lammerstraat 13, 9000 Gent
- Target audience: healthcare, industry, government and regulatory professionals and researchers
- Program & more info
- Registration
- Accreditation: RIZIV-INAMI accreditation requested for medical doctors
- Contact: atmp@uzgent.be & 09 332 98 02